Literature DB >> 7719349

Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein.

M A Whittington1, K C Sidle, I Gowland, J Meads, A F Hill, M S Palmer, J G Jefferys, J Collinge.   

Abstract

The prion protein (PrP) is central to the aetiology of the prion diseases, transmissible neurodegenerative conditions of humans and animals. PrP null mice show abnormalities of synaptic neurophysiology, in particular weakened GABAA receptor-mediated fast inhibition and impaired long-term potentiation in the hippocampus. Here we demonstrate that this PrP null phenotype is rescued in mice with a high copy number of a transgene encoding human PrP but not in low copy number mice, confirming the specificity of the phenotype for loss of function of PrP. The ability of human PrP to compensate for loss of murine PrP will allow direct study of the functional consequences of the 18 human PrP mutations, which cause the inherited prion diseases; this phenotype can now form the basis of the first functional assay for PrP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719349     DOI: 10.1038/ng0295-197

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  20 in total

Review 1.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 2.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 3.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Sleep and sleep regulation in normal and prion protein-deficient mice.

Authors:  I Tobler; T Deboer; M Fischer
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

Review 5.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

Review 6.  Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection?

Authors:  J W Almond; P Brown; S M Gore; A Hofman; P W Wientjens; R M Ridley; H F Baker; G W Roberts; K L Tyler
Journal:  BMJ       Date:  1995-11-25

7.  Gene expression profile in prion protein-deficient fibroblasts in culture.

Authors:  J Satoh; Y Kuroda; S Katamine
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

9.  Doxycycline control of prion protein transgene expression modulates prion disease in mice.

Authors:  P Tremblay; Z Meiner; M Galou; C Heinrich; C Petromilli; T Lisse; J Cayetano; M Torchia; W Mobley; H Bujard; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 10.  Impaired motor coordination in mice lacking prion protein.

Authors:  S Katamine; N Nishida; T Sugimoto; T Noda; S Sakaguchi; K Shigematsu; Y Kataoka; A Nakatani; S Hasegawa; R Moriuchi; T Miyamoto
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.